Literature DB >> 18181038

Molecular subtypes in breast cancer evaluation and management: divide and conquer.

Jeffrey Peppercorn1, Charles M Perou, Lisa A Carey.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18181038     DOI： 10.1080/07357900701784238

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  71 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

2.  Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.

Authors:  Kyueng-Whan Min; Dong-Hoon Kim; Sung-Im Do; Seoung Wan Chae; Kyungeun Kim; Jin Hee Sohn; Jung-Soo Pyo; Hyun Joo Lee; Dong Hyun Kim; Sukjoong Oh; Seon Hyeong Choi; Yong Lai Park; Chan Heun Park; Eun-Kyung Kim; Mi Jung Kwon; Jinwon Seo; Kyoung Min Moon
Journal:  Virchows Arch       Date:  2015-12-30       Impact factor: 4.064

3.  Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.

Authors:  Kyueng-Whan Min; Seoung Wan Chae; Dong-Hoon Kim; Sung-Im DO; Kyungeun Kim; Hyun Joo Lee; Jin Hee Sohn; Jung-Soo Pyo; Dong Hyun Kim; Sukjoong Oh; Seon Hyeong Choi; Yong Lai Park; Chan Heun Park
Journal:  Oncol Lett       Date:  2015-05-08       Impact factor: 2.967

4.  Personalized therapy for pancreatic cancer: Myth or reality in 2010?

Authors:  Tzu-Chuan Jane Huang; Siddhartha Kar; Milind Javle
Journal:  J Gastrointest Oncol       Date:  2010-09

5.  Defining the cellular precursors to human breast cancer.

Authors:  Patricia J Keller; Lisa M Arendt; Adam Skibinski; Tanya Logvinenko; Ina Klebba; Shumin Dong; Avi E Smith; Aleix Prat; Charles M Perou; Hannah Gilmore; Stuart Schnitt; Stephen P Naber; Jonathan A Garlick; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-21       Impact factor: 11.205

Review 6.  Role of epithelial stem/progenitor cells in mammary cancer.

Authors:  Robert D Bruno; Gilbert H Smith
Journal:  Gene Expr       Date:  2011

Review 7.  Personalized medicine in oncology: the future is now.

Authors:  Richard L Schilsky
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

8.  Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells.

Authors:  Vikas Sehdev; James C K Lai; Alok Bhushan
Journal:  J Oncol       Date:  2010-02-11       Impact factor: 4.375

9.  Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.

Authors:  Alfonso Sánchez-Muñoz; Elena Gallego; Vanessa de Luque; Luís G Pérez-Rivas; Luís Vicioso; Nuria Ribelles; José Lozano; Emilio Alba
Journal:  BMC Cancer       Date:  2010-04-13       Impact factor: 4.430

Review 10.  Histological and molecular types of breast cancer: is there a unifying taxonomy?

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.